A government tender has cleared the final procedural hurdle for the E1 settlement east of Jerusalem and calls for bids to develop 3,401 housing units; the monitoring group Peace Now said initial work could begin within a month.
Scotiabank chief executive Scott Thomson said rising U.S. influence and a more pro-business climate in parts of Latin America could support the bank's international growth strategy; the bank's overseas focus is on Mexico, Peru, Chile and Colombia and forms part of a turnaround plan launched in late 2023.
Edmonton police have laid charges against nine additional men in an ongoing investigation into the One Order Motorcycle Club, launched in October 2024; the probe is described by police as part of their guns and gangs strategy.
Robert "Bob" Langdon died January 4, 2026 at Espanola Regional Hospital, surrounded by family; a Celebration of Life will be held January 10, 2026 at the Nairn Centre Community Centre.
Dallas police say 16-year-old Norman Prater, missing since 1973, has been identified after a photo linked him to a 1973 Aransas County hit-and-run victim; no suspect has been arrested.
Astronomers report that Cloud 9, a nearby gas cloud about 14 million light-years away, contains neutral hydrogen but shows no detectable stars; follow-up Hubble imaging supports its identification as a Reionization-Limited H I Cloud (RELHIC). The finding aligns with a Lambda-CDM prediction that some dark-matter haloes can remain starless.
Sarah Michelle Gellar is one of three judges announced for Netflix's revival of the 1980s talent competition Star Search, which premieres January 20 and will air live for 10 episodes; Anthony Anderson is reported as the host.
The article reports researcher Shanmukha Sreenivas Madras is developing adjusted culture methods and multiplex qPCR assays to speed molecular diagnosis and has created quality-management frameworks to support clinical validation.
Nestlé is voluntarily recalling certain batches of SMA, BEBA and NAN infant formulas in several countries over possible cereulide contamination; the company and the Canadian Food Inspection Agency say the recall does not affect products sold in Canada.
Phase 3 HERIZON‑GEA‑01 reported that Ziihera plus tislelizumab and chemotherapy achieved a median overall survival of 26.4 months, and both Ziihera combinations improved progression‑free survival versus trastuzumab plus chemotherapy.
